Brand and Other Names:Fanapt
- Classes: Antipsychotics, 2nd Generation
Dosing & Uses
Dosage Forms & Strengths
Day 1: 1 mg PO q12hr; increase qDay to effective dose of 6-12 mg PO q12hr
Day 2: 2 mg PO q12hr, THEN increase qDay by 2 mg/day to effective dose of 6-12 mg PO q12hr; not to exceed 24 mg/day
Must gradually increase dose to avoid orthostatic hypotension
Coadministration with strong CYP2D6 or CYP3A4 inhibitors: Decrease iloperidone dose by 50%
Poor CYP2D6 metabolizers: Decrease iloperidone dose by 50%
Renal impairment: Unlikely to have a significant impact since <1% of drug is excreted unchanged in urine
- Mild: No dosage adjustment required
- Moderate: Caution advised
- Severe: Use not recommended
Safety and efficacy not established
Serious - Use Alternative
Significant - Monitor Closely
Dry mouth (15%)
Frequency Not Defined (selected)
Hypersensitivity reactions (including anaphylaxis; angioedema; throat tightness; oropharyngeal swelling; swelling of the face, lips, mouth, and tongue; urticaria; rash; and pruritus)
Black Box Warnings
Patients with dementia-related psychosis who are treated with antipsychotic drugs are at an increased risk of death as shown in short-term controlled trials
The deaths appeared to be either cardiovascular (eg, heart failure, sudden death) or infectious (eg, pneumonia) in nature
This drug is not approved for the treatment of patients with dementia-related psychosis
Hypersensitivity; anaphylaxis, angioedema, and other hypersensitivity reactions reported
Prolongs QT interval; caution with other drugs/conditions that increase QTc
Not recommended in hepatic impairment
Risk of neuroleptic malignant syndrome and extrapyramidal symptoms
May cause anticholinergic side effects (eg., confusion, agitation)
Blood dyscrasias (leukopenia, neutropenia, agranulocytosis) may occur
Orthostatic hypotension may occur
Cases of priapism reported
Motor and cognitive impairment may occur; use caution when operating heavy machinery
Use caution in patients with history of seizures or with conditions that lower seizure threshold
Monitor closely patients at high risk of committing suicide
Hyperprolactinemia may occur; gynecomastia and galactorrhea reported
Antipsychotic agents may disrupt body temperature regulation and may cause esophageal dysmotility and aspiration; use caution
- Atypical antipsychotics have been associated with metabolic changes that may increase cardiovascular/cerebrovascular risk including hyperglycemia, dyslipidemia, and body weight gain
- Increased risk of hyperglycemia and diabetes; in some cases, hyperglycemia concomitant with use of atypical antipsychotics has been associated with ketoacidosis, hyperosmolar coma, or death
- Monitor blood glucose of high risk patients
- Possibility of weight gain
Pregnancy & Lactation
Pregnancy Category: C
Neonates exposed to antipsychotic drugs during the 3rd trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery
These complications vary in severity; in some cases, symptoms have been self-limited, while in other cases neonates have required intensive care unit support and prolonged hospitalization
Lactation: not known if excreted in breast milk, do not nurse
A:Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B:May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C:Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D:Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X:Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA:Information not available.
Mechanism of Action
May act by antagonizing a combination of dopamine type 2 (D2) and serotonin type 2 (5-HT2) receptors.
Peak Plasma Time: 2-4 hr
Protein Bound: 95%
Vd: 1340-2800 L
Metabolized by CYP2D6 and CYP3A4
Excretion: Urine (45-58%), feces (20-22%)
To view formulary information first create a list of plans. Your list will be saved and can be edited at any time.
Adding plans allows you to:
- View the formulary and any restrictions for each plan.
- Manage and view all your plans together – even plans in different states.
- Compare formulary status to other drugs in the same class.
- Access your plan list on any device – mobile or desktop.
The above information is provided for general informational and educational purposes only. Individual plans may vary and formulary information changes. Contact the applicable plan provider for the most current information.
|1||This drug is available at the lowest co-pay. Most commonly, these are generic drugs.|
|2||This drug is available at a middle level co-pay. Most commonly, these are "preferred" (on formulary) brand drugs.|
|3||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs.|
|4||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.|
|5||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.|
|6||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.|
|NC||NOT COVERED – Drugs that are not covered by the plan.|
Drugs that require prior authorization. This restriction requires that specific clinical criteria be met prior to the approval of the prescription.
Drugs that have quantity limits associated with each prescription. This restriction typically limits the quantity of the drug that will be covered.
Drugs that have step therapy associated with each prescription. This restriction typically requires that certain criteria be met prior to approval for the prescription.
Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription.
Select a box to add or remove a plan.
Select a class to view formulary status for similar drugs